MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

Strona główna・Stock List・NeoGenomics Inc

NeoGenomics Inc

Closed

12.63 -1.1

Buy Sell

Overview

Share price change

24h

Current

Min

12.24

Max

12.77

Key metrics
By Trading Economics
Income	18M -27M
Sales	6.5M 188M
Profit margin	-14.446
Employees	2,200
EBITDA	38M -10M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+9.46% upside

Dividends
By Dow Jones
Next Earnings	17 lut 2026

Market Stats
By TradingEconomics
Market Cap	304M 1.6B
Previous open	13.73
Previous close	12.63

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

7.7 / 10.27 Support & Resistance

NeoGenomics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

16 sty 2026, 16:01 UTC

Major Market Movers

Acquisitions, Mergers, Takeovers

Riot Platforms Shares Rise After Texas Land Buy, Data Center Lease

15 sty 2026, 17:51 UTC

Major Market Movers

Galaxy Digital Climbs on Texas Data-Center Expansion Approval, Tokenized CLO Issuance

6 sty 2026, 17:41 UTC

Major Market Movers

Blink Charging Shares Rise as EV Chargers Begin Accepting Cryptocurrency

20 sty 2026, 13:42 UTC

Market Talk

Cryptocurrencies Fall as Risk Aversion Drives Global Stocks Lower -- Market Talk

20 sty 2026, 11:53 UTC

Earnings

U.S. Bancorp Says It Has Completed Pilot to Enable Cross-Border Stablecoin Transactions >USB

20 sty 2026, 08:13 UTC

Market Talk

Bitcoin, Ether Fall on Risk Aversion Over U.S.-Europe Tensions -- Market Talk

19 sty 2026, 13:29 UTC

Market Talk

Recovery in Bitcoin, Ether Stall Amid U.S.-Europe Tensions -- Market Talk

19 sty 2026, 07:15 UTC

Market Talk

Cryptocurrencies Fall Amid Risk-Off Sentiment -- Market Talk

16 sty 2026, 13:35 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 sty 2026, 13:35 UTC

Market Talk

Demand For Potential Digital Euro Will Determine Its Impact -- Market Talk

16 sty 2026, 08:08 UTC

Market Talk

Bitcoin Falls as Traders Take Profits -- Market Talk

15 sty 2026, 08:23 UTC

Market Talk

Bitcoin Eases Following Falls in Tech Stocks -- Market Talk

14 sty 2026, 08:19 UTC

Market Talk

Bitcoin Rises on Optimism Over Crypto Regulation, Rate Cut Bets -- Market Talk

14 sty 2026, 08:19 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 sty 2026, 06:00 UTC

Earnings

The First Crypto IPO of 2026 Is Coming Soon. It's a Risky Bet. -- Barrons.com

14 sty 2026, 05:30 UTC

Market Talk

Bitcoin Climbs After Decisive Range Breakout, Technical Analysis Shows -- Market Talk

13 sty 2026, 13:09 UTC

Market Talk

Ethereum Could Outperform Bitcoin as Its Prospects Improve -- Market Talk

13 sty 2026, 13:02 UTC

Acquisitions, Mergers, Takeovers

Bitcoin Depot Acquires the Assets of Regional Bitcoin ATM Operator, Instant Coin Bank

13 sty 2026, 11:05 UTC

Market Talk

Outflows From Crypto Funds Hold Back Recovery -- Market Talk

13 sty 2026, 08:16 UTC

Market Talk

Bitcoin Edges Higher After U.S. Stocks Rise -- Market Talk

12 sty 2026, 17:51 UTC

Market Talk

Stablecoin Adoption Seen as Gradual Threat to Traditional Fintech -- Market Talk

12 sty 2026, 16:01 UTC

Market Talk

Bitcoin Seen as Alternative Amid Fed Independence Worries -- Market Talk

12 sty 2026, 13:05 UTC

Acquisitions, Mergers, Takeovers

Bakkt Holdings: To Continue to Trade on NY Stk Exchange Under the Ticker Symbol BKKT >BKKT

12 sty 2026, 13:05 UTC

Acquisitions, Mergers, Takeovers

Bakkt Holdings: Intend to Change Its Corporate Name to Bakkt Inc. >BKKT

12 sty 2026, 13:04 UTC

Acquisitions, Mergers, Takeovers

Bakkt Holdings Intercontinental Exchange, Which Beneficially Owns About 31% of Bakkt's Outstanding Class A Common Stk, Has Agreed to Vote Such Shrs in Favor of the Transaction >BKKT

12 sty 2026, 09:38 UTC

Market Talk

Bitcoin Trims Gains as Fed Independence Concerns Mount -- Market Talk

9 sty 2026, 08:00 UTC

Market Talk

Bitcoin Falls Ahead of U.S. Jobs Data -- Market Talk

8 sty 2026, 07:59 UTC

Market Talk

Bitcoin Falls as Traders Take Profits After Recent Gains -- Market Talk

6 sty 2026, 12:26 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 sty 2026, 12:26 UTC

Market Talk

Geopolitical Tensions Could Benefit Bitcoin -- Market Talk

Peer Comparison

Price change

NeoGenomics Inc Forecast

Price Target

By TipRanks

9.46% upside

12 Months Forecast

Average 14 USD 9.46%

High 16 USD

Low 12 USD

Based on 11 Wall Street analysts offering 12 month price targets forNeoGenomics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

Buy

Hold

Sell

Based on 11 analysts giving stock ratings to NeoGenomics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

7.7 / 10.27Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.